» Articles » PMID: 29534306

The Hepatic BMAL1/AKT/lipogenesis Axis Protects Against Alcoholic Liver Disease in Mice Via Promoting PPARα Pathway

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2018 Mar 14
PMID 29534306
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Alcohol liver disease (ALD) is one of the major chronic liver diseases worldwide, ranging from fatty liver, alcoholic hepatitis, cirrhosis, and potentially, hepatocellular carcinoma. Epidemiological studies suggest a potential link between ALD and impaired circadian rhythms, but the role of hepatic circadian proteins in the pathogenesis of ALD remains unknown. Here we show that the circadian clock protein BMAL1 in hepatocytes is both necessary and sufficient to protect mice from ALD. Ethanol diet-fed mice with liver-specific knockout (Bmal1-LKO) or depletion of Bmal1 develop more severe liver steatosis and injury as well as a simultaneous suppression of both de novo lipogenesis and fatty acid oxidation, which can be rescued by the supplementation of synthetic PPARα ligands. Restoring de novo lipogenesis in the liver of Bmal1-LKO mice by constitutively active AKT not only elevates hepatic fatty acid oxidation but also alleviates ethanol-induced fatty liver and liver injury. Furthermore, hepatic over-expression of lipogenic transcription factor ChREBP, but not SREBP-1c, in the liver of Bmal1-LKO mice also increases fatty acid oxidation and partially reduces ethanol-induced fatty liver and liver injury. Conclusion: we identified a protective role of BMAL1 in hepatocytes against ALD. The protective action of BMAL1 during alcohol consumption depends on its ability to couple ChREBP-induced de novo lipogenesis with PPARα-mediated fatty oxidation. (Hepatology 2018).

Citing Articles

Circadian rhythms and inflammatory diseases of the liver and gut.

Ferrell J Liver Res. 2025; 7(3):196-206.

PMID: 39958387 PMC: 11791922. DOI: 10.1016/j.livres.2023.08.004.


Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models.

Hong X, Huang S, Jiang H, Ma Q, Qiu J, Luo Q Front Pharmacol. 2024; 15:1432480.

PMID: 39669199 PMC: 11635172. DOI: 10.3389/fphar.2024.1432480.


Saikogenin A improves ethanol-induced liver injury by targeting SIRT1 to modulate lipid metabolism.

Jiang M, Feng Y, Wang J, Xu X, Liu Z, Li T Commun Biol. 2024; 7(1):1547.

PMID: 39572758 PMC: 11582619. DOI: 10.1038/s42003-024-07234-x.


Circadian Regulation of Lipid Metabolism during Pregnancy.

Luo Y, Meng X, Cui L, Wang S Int J Mol Sci. 2024; 25(21).

PMID: 39519044 PMC: 11545986. DOI: 10.3390/ijms252111491.


Circadian Clock Disruption and Growth of Kidney Cysts in Autosomal Dominant Polycystic Kidney Disease.

Jamadar A, Ward C, Remadevi V, Varghese M, Pabla N, Gumz M J Am Soc Nephrol. 2024; 36(3):378-392.

PMID: 39401086 PMC: 11888963. DOI: 10.1681/ASN.0000000528.


References
1.
Sanchez-Gurmaches J, Tang Y, Jespersen N, Wallace M, Calejman C, Gujja S . Brown Fat AKT2 Is a Cold-Induced Kinase that Stimulates ChREBP-Mediated De Novo Lipogenesis to Optimize Fuel Storage and Thermogenesis. Cell Metab. 2017; 27(1):195-209.e6. PMC: 5762420. DOI: 10.1016/j.cmet.2017.10.008. View

2.
Tsutsumi And M, Takase S . Effect of fenofibrate on fatty liver in rats treated with alcohol. Alcohol Clin Exp Res. 2001; 25(6 Suppl):75S-9S. DOI: 10.1097/00000374-200106001-00017. View

3.
Forcheron F, Cachefo A, Thevenon S, Pinteur C, Beylot M . Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients. Diabetes. 2002; 51(12):3486-91. DOI: 10.2337/diabetes.51.12.3486. View

4.
Tamaru T, Hirayama J, Isojima Y, Nagai K, Norioka S, Takamatsu K . CK2alpha phosphorylates BMAL1 to regulate the mammalian clock. Nat Struct Mol Biol. 2009; 16(4):446-8. PMC: 6501789. DOI: 10.1038/nsmb.1578. View

5.
Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F . SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell. 2008; 134(2):317-28. DOI: 10.1016/j.cell.2008.06.050. View